Cargando…

Quasispecies of genotype 4 of hepatitis C virus genomes in Saudi patients managed with interferon alfa and ribavirin therapy

BACKGROUND AND OBJECTIVES: Many patients with hepatitis C virus (HCV) infection do not respond to antiviral treatment, possibly due to viral quasispecies. We aimed to investigate whether the quasispeices population could be used as a predictor of response to therapy in our patients. METHODS: The qua...

Descripción completa

Detalles Bibliográficos
Autores principales:	Al-Qahtani, Ahmed A., Kessie, George, Cruz, Damian Dela, Al-Faleh, Faleh Z., Al-Ahdal, Mohammed N.
Formato:	Texto
Lenguaje:	English
Publicado:	Medknow Publications 2010
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2855060/ https://www.ncbi.nlm.nih.gov/pubmed/20220259 http://dx.doi.org/10.4103/0256-4947.60515

Ejemplares similares

Molecular epidemiology and genotyping of TT virus isolated from Saudi blood donors and hepatitis patients
por: Al-Mozaini, Maha A., et al.
Publicado: (2006)

Genetic variability of the core protein in hepatitis C virus genotype 4 in Saudi Arabian patients and its implication on pegylated interferon and ribavirin therapy
por: Alhamlan, Fatimah S, et al.
Publicado: (2014)

Hepatitis C virus core protein substitutions affect the response to pegylated-interferon and ribavirin therapy
por: Alhamlan, Fatimah S, et al.
Publicado: (2014)

Predictors of sustained virological response to a 48-week course of pegylated interferon alfa-2a and ribavirin in patients infected with hepatitis C virus genotype 4
por: Al Ashgar, Hamad, et al.
Publicado: (2009)

Prevailing genotypes of hepatitis C virus in Saudi Arabia: a systematic analysis of evidence
por: Abozaid, Suhair M., et al.
Publicado: (2013)

Hepatitis C virus quasispecies in chronically infected children subjected to interferon–ribavirin therapy
por: Figlerowicz, Magdalena, et al.
Publicado: (2010)

Epidemiology of Viral Hepatitis in Saudi Arabia: Are We Off the Hook?
por: Abdo, Ayman A., et al.
Publicado: (2012)

Hepatitis C Genotype 4: Genotypic Diversity, Epidemiological Profile, and Clinical Relevance of Subtypes in Saudi Arabia
por: Al Ashgar, Hamad I, et al.
Publicado: (2013)

IL28B polymorphisms predict the virological response to standard therapy in patients with chronic hepatitis C virus genotype 4 infection
por: Abdo, Ayman A., et al.
Publicado: (2013)

Human papilloma virus-16/18 cervical infection among women attending a family medical clinic in Riyadh
por: Al-Muammar, Tarfah, et al.
Publicado: (2007)

Subcutaneous Sarcoidosis during Pegylated Interferon Alfa and Ribavirin Treatment for Chronic Hepatitis C
por: Rodríguez-Lojo, R., et al.
Publicado: (2010)

Validation of three noninvasive laboratory variables to predict significant fibrosis and cirrhosis in patients with chronic hepatitis C in Saudi Arabia
por: Abdo, Ayman A., et al.
Publicado: (2007)

Extensive Psoriasis Induced by Pegylated Interferon Alfa-2a and Ribavirin in the Treatment of Chronic Hepatitis C
por: Kim, Gun-Wook, et al.
Publicado: (2013)

Consensus Interferon Plus Ribavirin for Hepatitis C Genotype 3 Patients Previously Treated With Pegylated Interferon Plus Ribavirin
por: Abbas, Zaigham, et al.
Publicado: (2013)

Baseline Serum Cholesterol Is Associated with a Response to Pegylated Interferon Alfa-2b and Ribavirin Therapy for Chronic Hepatitis C Genotype 2
por: Taura, Naota, et al.
Publicado: (2012)

Pediatric Tracheostomy: A Quality-of-Life Assessment Study in Saudi Arabia
por: Al-Faleh, Moath, et al.
Publicado: (2023)

Durability of a sustained virological response in chronic hepatitis C patients treated with pegylated interferon alfa and ribavirin
por: Choi, Sang Bun, et al.
Publicado: (2011)

Transient Visual Loss in a Hepatitis C Patient Treated With Pegylated Interferon Alfa-2a and Ribavirin
por: Jancoriene, Ligita, et al.
Publicado: (2014)

Peginterferon Alfa-2a plus Ribavirin in Japanese Patients Infected with Hepatitis C Virus Genotype 2 Who Failed Previous Interferon Therapy
por: Kanda, Tatsuo, et al.
Publicado: (2012)

The α Chemokine, Interleukin 8, Inhibits the Antiviral Action of Interferon α
por: Khabar, Khalid S.A., et al.
Publicado: (1997)

Hepatitis C Virus: Viral Quasispecies and Genotypes
por: Tsukiyama-Kohara, Kyoko, et al.
Publicado: (2017)

Short versus standard treatment with pegylated interferon alfa-2A plus ribavirin in patients with hepatitis C virus genotype 2 or 3: the cleo trial
por: Mecenate, Fabrizio, et al.
Publicado: (2010)

Aborting a Malformed Fetus: A Debatable Issue in Saudi Arabia
por: Al-Alaiyan, Saleh, et al.
Publicado: (2012)

Features and Associated Comorbidities of Laryngomalacia in Saudi Arabia
por: Alanzi, Omar, et al.
Publicado: (2023)

Cost-Efficacy Analysis of Peginterferon alfa-2b plus Ribavirin Compared With Peginterferon alfa-2a plus Ribavirin for the Treatment of Chronic Hepatitis C
por: Malone, Daniel C., et al.
Publicado: (2005)

Simeprevir with pegylated interferon alfa 2a plus ribavirin for treatment of hepatitis C virus genotype 1 in patients with HIV: a meta-analysis and historical comparison
por: Andersohn, Frank, et al.
Publicado: (2016)

Ribavirin Impairs Salivary gland function During Combination Treatment With Pegylated Interferon Alfa-2a In HEpatitis C patients
por: Aghemo, Alessio, et al.
Publicado: (2011)

Variations in DEPDC5 gene and its association with chronic hepatitis C virus infection in Saudi Arabia
por: Al-Anazi, Mashael R, et al.
Publicado: (2014)

The Association of Toll-Like Receptor 4 Polymorphism with Hepatitis C Virus Infection in Saudi Arabian Patients
por: Al-Qahtani, Ahmed A., et al.
Publicado: (2014)

Premedication for neonatal intubation: Current practice in Saudi Arabia
por: Mosalli, Rafat, et al.
Publicado: (2012)

Epidemiology, Disease Burden, and Treatment Strategies of Chronic Hepatitis C Virus Infections in Saudi Arabia in the New Treatment Paradigm Shift
por: Aljumah, Abdulrahman A., et al.
Publicado: (2016)

Changes in serum Interleukin-33 concentration before and after treatment with pegylated interferon alfa-2a plus ribavirin in patients with chronic hepatitis C genotype 1b infection
por: Cacopardo, Bruno, et al.
Publicado: (2012)

Ribavirin and interferon alfa-2a for severe Middle East respiratory syndrome coronavirus infection: a retrospective cohort study
por: Omrani, Ali S, et al.
Publicado: (2014)

Oxidative status and the response to pegylated-interferon alpha2a plus ribavirin in chronic genotype 4 HCV hepatitis
por: Ahmed, Mohammed Mahmound, et al.
Publicado: (2013)

Association between HLA Variations and Chronic Hepatitis B Virus Infection in Saudi Arabian Patients
por: Al-Qahtani, Ahmed A., et al.
Publicado: (2014)

Public awareness of diabetes complications and its effect on treatment compliance in Asir region, Saudi Arabia
por: Alhammadi, Nouf Ahmed, et al.
Publicado: (2022)

Neonatal Short-Term Outcomes of Gestational Diabetes Mellitus in Saudi Mothers: A Retrospective Cohort Study
por: Al-Khalifah, R., et al.
Publicado: (2012)

Oxidative stress and antioxidant defense in patients with chronic hepatitis C patients before and after pegylated interferon alfa-2b plus ribavirin therapy
por: Levent, Görenek, et al.
Publicado: (2006)

Rheumatoid arthritis following PEG-interferon-alfa-2a plus ribavirin treatment for chronic hepatitis C: a case report and review of the literature
por: Cacopardo, Bruno, et al.
Publicado: (2013)

Hepatitis C Viral Kinetics as a Determinant of Stopping Pegylated Interferon and Ribavirin in Genotype 1 Infection
por: Kim, Do Young
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_0rhct7sh2gvga004fgc8073gmf